Cost-Effective Interventions for HIV, Malaria, ...

By Rene Pretorius

April 14, 2025

Limited healthcare budgets demand smart investments. Low- and middle-income countries battle HIV/AIDS, malaria, syphilis, and tuberculosis. A recent
Toripalimab Evidence Journey in Cancer Care
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
Catalyzing Value-Based Care Through Patient-Centered Outcomes
Pharmaceutical Innovation and Market Access: Insights from Fast Company’s 202...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
South Africa’s Innovative Strategy for Cervical Cancer Prevention
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Effective Management of Diabetes in Arab Region: Insights and Strategies
Healthcare for Older Adults in Türkiye: A Call for Reform